Suche ›

Cell Therapy for Perinatal Brain Injury

Springer Singapore,
106,99 € Lieferbar ab 09.04.2017


This book provides a wealth of insights, advances and new perspectives on cell therapy for different types of neonatal ischemic disease, such as Hypoxic-Ischemic Encephalopathy (HIE), Periventricular Leukomalacia (PVL) and neonatal infarction. These diseases pose serious challenges for neonatologists and neurologists, because the severe sequelae lead to decreasing QOL for patients and their families. Accordingly, new treatments for neonatal ischemic diseases are needed all over the world. The book develops new effective therapies combined with hypothermia therapy, an established treatment for HIE. After reviewing past approaches, it presents cutting-edge topics in cell therapy, one of the most promising candidates for treating neonatal ischemic disease. Cell therapy for Neonatal Ischemic Disease will offer readers a better understanding of the current state of the art in this field from bench to bedside, and inspire researchers and physicians to further explore this evolving therapy.


Titel: Cell Therapy for Perinatal Brain Injury
Autoren/Herausgeber: Haruo Shintaku, Akira Oka, Makoto Nabetani (Hrsg.)
Ausgabe: 1st ed. 2017

ISBN/EAN: 9789811014116

Seitenzahl: 120
Format: 23,5 x 15,5 cm
Produktform: Hardcover/Gebunden
Gewicht: 0 g
Sprache: Englisch

Haruo Shintaku, Osaka City Univ. Grad. School of Med., Department of PediatricsAkira Oka, University of Tokyo, Department of PediatricsMakoto Nabetani, Yodogawa Christian Hospital, Hospice/Children's Hospice Hospital - Newsletter
Möchten Sie sich für den Newsletter anmelden?

Bitte geben Sie eine gültige E-Mail-Adresse ein.
Lieber nicht